Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Expenses:    
Research and Development $ 3,448,925 $ 5,350,264
General and Administrative 8,277,993 5,323,649
Goodwill Impairment 0 4,037,811
Change in Fair Value of Contingent Consideration 582,605 (475,956)
Total Operating Expenses 12,309,523 14,235,768
Operating Loss Before Other Income (12,309,523) (14,235,768)
Other (Expense) Income, Net:    
Change in Fair Value of Warrant Liability (1,425,102) 0
Gain on Forgiveness of Loan 0 278,190
Gain on Disposal of Fixed Assets 4,211 0
Interest Income 56,891 1,141
Interest Expense (8,599) (6,851)
Foreign Currency Loss (14,498) 0
Total Other (Expense) Income, Net (1,387,097) 272,480
Loss Before Income Tax Benefit (13,696,620) (13,963,288)
Income Tax Benefit 113,010 192,603
Net Loss $ (13,583,610) $ (13,770,685)
Net Loss per Common Share - Basic (in usd per share) $ (18.55) $ (57.12)
Net Loss per Common Share - Diluted (in usd per share) $ (18.55) $ (57.12)
Weighted Average Shares Outstanding - Basic (in shares) 732,303 241,099
Weighted Average Shares Outstanding - Diluted (in shares) 732,303 241,099
Other Comprehensive Loss:    
Net Loss $ (13,583,610) $ (13,770,685)
Foreign Currency Translation Adjustments (96,310) (85,629)
Comprehensive Loss $ (13,679,920) $ (13,856,314)